skip to content

Cambridge Stem Cell Institute

 
Read more at: SCI-TIF gather for 2nd Annual Networking Dinner
Collage of photos from the networking dinner

SCI-TIF gather for 2nd Annual Networking Dinner

16 May 2024

This month the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF ) gathered to celebrate their 2 nd Annual Networking Dinner. SCI-TIF members, CSCI Principal Investigators , and Stem Cell Interdisciplinary Research Centre members got together at SIX Restaurant at the Varsity to meet, discuss...


Read more at: CSCI Postgraduates take a break from the bench at this year's Postgraduate Away Day
Collage of photos from the 2024 Postgraduate Away Day

CSCI Postgraduates take a break from the bench at this year's Postgraduate Away Day

7 May 2024

Recently the CSCI PhD and MPhil students got together for their annual Postgraduate Away Day for a day of talks, brainstorming sessions, and a pub quiz. The event, planned by the student committee, took place on 25 April. The 25 new students from the October 2023 intake (pictured) under the supervision of 16 different PIs...


Read more at: ‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention in new study by the Khaled Group
Immune cell exhaustion observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa

‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention in new study by the Khaled Group

28 March 2024

Researchers at CSCI and University of Cambridge have created the world’s largest catalogue of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations. The study, published today (28 March) in the journal Nature Genetics from r esearchers in the Khaled Group in the...


Read more at: CSCI Hot Topic Event covers AI’s impact on stem cell research & medicine
Collage of photos from the event - exhibition tables, reception, and panel discussion

CSCI Hot Topic Event covers AI’s impact on stem cell research & medicine

20 March 2024

This week (Monday 18 March) , members of the Cambridge Stem Cell Institute, the Technology and Innovation Forum ( SCI-TIF ) and guests from around Cambridge convened to delve into the pressing subject of AI’s role in advancing stem cell research and medicine ( see the poster here ). The event began with a welcome by...


Read more at: Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds
A cell aggregation of human pluripotent stem cells and amniotic ectoderm cells. Credit Shota Nakanoh

Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds

8 March 2024

Research published this week in Science Advances by Dr Shota Nakanoh in a collaboration between Dr Teresa Rayon’s lab at the Institute and Professor Ludovic Vallier’s lab at the Wellcome-MRC Cambridge Stem Cell Institute has determined that the degree of cell crowding in the early human embryo influences whether cells...


Read more at: New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

12 February 2024

Professor Walid Khaled from CSCI and co-leader Dr Laura Greaves from Newcastle have received UKRI funding for research on age-related biological changes in model organisms as part of a national collaboration. UKRI funding of £3 million is awarded today (12 February) to support a new research cluster as part of the MRC...


Read more at: CSCI’s first Trainee Day kicks off SCI-TIF’s 2024 events programme

CSCI’s first Trainee Day kicks off SCI-TIF’s 2024 events programme

8 February 2024

This Tuesday (6 February), our Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) and Institute researchers participated in our first SCI-TIF event of 2024, highlighting collaboration between industry and academia. The event started with an introduction from CSCI Director Bertie Gottgens, then...


Read more at: Professor Vassiliou to spearhead £4m project to develop clinical platform for blood cancer prevention with Blood Cancer UK and Leukemia & Lymphoma Society in the US

Professor Vassiliou to spearhead £4m project to develop clinical platform for blood cancer prevention with Blood Cancer UK and Leukemia & Lymphoma Society in the US

5 February 2024

On World Cancer Day yesterday (4 February), Blood Cancer UK and the American charity Leukemia & Lymphoma Society (LLS) announced the start of a transformative five-year, £4 million research project in Cambridge, spearheaded by CSCI’s Professor George Vassiliou. The project aims to establish a clinical platform to...


Read more at: Role of inherited genetic variants in rare blood cancer uncovered by CSCI researchers and collaborators
Blood cells

Role of inherited genetic variants in rare blood cancer uncovered by CSCI researchers and collaborators

17 January 2024

Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer. Researchers from the Wellcome-MRC Cambridge Stem Cell Institute, Wellcome Sanger Institute, the University of Cambridge, and collaborators...


Read more at: Göttgens Group publishes research on a new model

Göttgens Group publishes research on a new model

8 January 2024

A new collaborative paper from the Göttgens , Kranc and O’Carroll groups reports the first model of homeostatic in vivo tissue dynamics that is anchored in single cell genomics data in the Cell Stem Cell publication out last week (5 January). In time series measurements extending over 9 months, the Kranc Group (Institute...